Premature Discontinuation of Contraceptive Implants

Launched by UNIVERSITY OF COLORADO, DENVER · Mar 30, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how to improve the experience of young women using the etonogestrel contraceptive implant, which is a small rod placed under the skin to prevent pregnancy. The researchers want to see if providing additional resources, like combined oral contraceptive pills (COCs) and a plan to manage any unexpected bleeding, can help reduce the number of women who stop using the implant compared to standard counseling.

To participate, you need to be a female between the ages of 14 and 22.9 who is starting the etonogestrel implant for the first time. Unfortunately, if you have any health issues that prevent you from using estrogen-based birth control, are planning to become pregnant soon, or will be moving away in the next year, you won't be eligible for this study. Participants will receive guidance and support throughout the trial to help them feel more comfortable with their contraceptive choice.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. You are between ages of 14 to 22.9 years.
• • 2. Started etonogestrel implant for the first time and have never used the implant before.
• Exclusion Criteria:
• • 1. There is any contraindication to estrogen containing birth control.
• • 2. Desire of pregnancy in next 12 months.
• • 3. Plans to move from the area in next 12 months and is not able to come to the clinic.